Iso hóa và đặc trưng của chủng vi khuẩn probiotic tiềm năng, Bacillus amyloliquefaciens, từ đất vùng Himalaya Đông Bắc dựa trên các đặc tính chức năng in vitro và in vivo

Bhakta JN, Ohnishi K, Munekage Y, Iwasaki K (2010) Isolation and probiotic characterization of arsenic-resistant lactic acid bacteria for uptaking arsenic. World Academy of Science. Eng Technol 71:470–471 Blandizzi C, Natale G, Gherardi G, Lazzeri G, Marveggio C, Colucci R, Carignani D, Del Tacca M (1999) Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury. Dig Dis Sci 44:2039–2050 Bobin-Dubigeon C, Collin X, Grimaud N, Robert JM, Le Baut G, Petit JY (2001) Effects of tumor necrosis factor-synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis. Eur J Pharmacol 421:103–110 Cetinkaya A, Bulbuloglu E, Kantarceken B, Ciralik H, Kurutas EB, Buyukbese MA, Gumusalan Y (2006) Effects of L-carnitine on oxidant/antioxidant status in acetic acid-induced colitis. Dig Dis Sci 51:488–494 Chen CC, Walker WA (2005) Probiotics and prebiotics: role in clinical disease states. Adv Pediatr 52:77–113 Deniz M, Cetinel S, Kurtel H (2004) Blood flow alterations in tnbs-induced colitis: role of endothelin receptors. Inflamm Res 53:329–336 EFSA (2004) Opinion of the scientific panel on additives and products or substances used in animal feed on a request from the Commission on the safety of the product “Kemzyme W Dry” regarding the ability of Bacillus strains involved in the manufacture to produce toxins. EFSA J 118:1–4 EFSA (2007) European food safety authority. Introduction of a qualified presumption of safety (QPS) approach for assessment of selected microorganisms referred to EFSA opinion of the scientific committee (Question No EFSA-Q-2005–293). Adopted on 19 November 2007. EFSA J 587:1–16 EFSA (2008) Scientific opinion of the panel on additives and products or substances used in animal feed (FEEDAP) on a request from the European Commission on the safety and efficacy of Ecobiol® (Bacillus amyloliquefaciens) as feed additive for chickens for fattening. EFSA J 773:1–13 Einerhand AW, Renes IB, Makkink MK, Vander Sluis M, Buller HA, Dekker J (2002) Role of mucins in inflammatory bowel disease: important lessons from experimental models. Eur J Gastroenterol Hepatol 14:757–765 Gaggia F, Mattarelli P, Biavati B (2010) Probiotics and prebiotics in animal feeding for safe food production. Int J Food Microbiol 141:S15–S28 Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, Poggioli G, Miglioli M, Campieri M (2003) Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124:1202–1209 Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S (1992) Survival of Lactobacillus species (strain GG) in the human gastrointestinal tract. Dig Dis Sci 37:121 Grisham MB, Beniot JN, Granger DN (1990) Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol 186:729–742 Guarnera F, Schaafsmab GJ (1998) Probiotics. Int J Food Microbiol 39:237–238 Havenaar R, Brink NG, Huis In’t Ved JHJ (1992) Selection of strains for probiotics use. In: Fuller R (ed) Probiotics, the scientific basis. Chapman & Hall, London, pp 210–224 Immerseel FV, Ducatelle R, De Vos M, Boon N, Wiele TVD, Verbeke K, Rutgeerts P, Sas B, Louis P, Flint HJ (2010) Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. J Med Microbiol 59:141–143 Ishikawa H, Akedo I, Umesaki Y et al (2003) Randomized controlled trial of the effect of Bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 22:56–63 Kim YG, Moon JT, Lee KM et al (2006) The effects of probiotics on symptoms of irritable bowel syndrome. Korean J Gastroenterol 47:413–419 Kos B, Suskovic J, Vukovic S, Simpraga M, Frece J, Matosic S (2003) Adhesion and aggregation ability of probiotic strain Lactobacillus acidophilus M92. J Appl Microbiol 94:981–987 Kravtsov EG, Yermolayev AV, Anokhina IV, Yashina NV, Chesnokova VL, Dalin MV (2008) Adhesion characteristics of Lactobacillus is a criterion of the probiotic choice. Bull Exp Biol Med 145:232–234 Kruis W, Schutz E, Fric P et al (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11:853–858 Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116:1107–1114 Makharia GK, Sood A, Midha V (2008) 701 A randomised, double blind, placebo controlled trial of a probiotic preparation, VSL#3, for the treatment of mild to moderate active ulcerative colitis. Gastroenterology 134:A-99 Markert M, Andrews PC, Babior BM (1984) Measurement of O2 production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods Enzymol 105:358–365 Mayra-Makinen A, Manninen M, Gyllenberg H (1983) The adherence of lactic acid bacteria to the columnar epithelial cells of pigs and calves. J Appl Bacteriol 55:241–245 Mileti E, Matteoli G, Iliev ID, Rescigno M (2009) Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One 4:7056 Ng SC, Plamondon S, Al-Hassi HO et al (2008) Effective probiotic treatment (VSL#3), but not placebo, in acute ulcerative colitis is associated with downregulation of inflammatory intestinal dendritic cells. Gut 57:96 Pelletier C, Bouley C, Cayuela C, Bouttier S, Bourlioux P, Bellon-Fontaine MN (1997) Cell surface characteristics of Lactobacillus casei subsp. casei, Lactobacillus paracasei subsp. paracasei, and Lactobacillus rhamnosus strains. Appl Environ Microbiol 63:1725–1731 Phelps RJ, McKillip JL (2002) Enterotoxin production in natural isolates of Bacillaceae outside the Bacillus cereus group. Appl Environ Microbiol 68:3147–3151 Prakash S, Urbanska AM (2008) Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells. Biologics 2:355–378 Prasad J, Gill H, Smart J, Gopal PK (1998) Selection and characterization of Lactobacillus and Bifidobacterium strains for use as probiotics. Int Dairy J 8:993–1002 Prisciandaro LMG, Butler R, Cummins A, Howarth G (2009) Probiotics and their derivatives as treatments for inflammatory bowel disease. Inflamm Bowel Dis 15:1906–1914 Ramon MA, Villegas I, Sanchez-Hidalgo M, Catalina AL (2006) The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol 147:873–885 Rochat T, Bermudez-Humaran L, Gratadoux J, Fourage C, Hoebler C, Corthier G, Langella P (2007) Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice. Microb Cell Fact 6:22 Saavedra JM, Bauman NA, oung L, Perman JA, Yolken RH (1994) Feeding of Bifidobacterium and Streptococcus thermophilus to infants in hospital to prevent diarrhea and shedding of rotavirus. Lancet 344:1046–1049 Sartor RB (1994) Cytokines in intestinal inflammation: pathophysiological and clinical consideration. Gastroenterology 106:533–539 Sonia M, Harshavardhan K (2011) Gut microbiota is not modified by randomized, double-blind, placebo-controlled trial of VSL#3 in diarrhea-predominant irritable bowel syndrome. Probiotics Antimicrob Proteins 3:1–7 Succi M, Tremonte P, Reale A, Sorrentino E, Grazia L, Pacifico S, Coppola R (2005) Bile salt and acid tolerance of Lactobacillus rhamnosus strains isolated from Parmigiano Reggiano cheese. FEMS Microbiol 244:129–137 Torres MI, Garci′A-Martin M, Gil A, Rios A (1999) Experimental colitis induced by trinitrobenzenesulphonic acid. An ultrastructural and histochemical study. Digest Dis Sci 44:2523–2529 Ueda M, Mozaffar S, Tanaka A (1990) Catalase from Candida boidinii 2201. Methods Enzymol 188:463–467 Vesterlund S, Paltta J, Karp M, Ouwehand AC (2005) Measurement of bacterial adhesion: in vitro evaluation of different methods. J Microbiol Methods 60:225–233 Whorwell PJ, Altringer L, Morel J et al (2006) Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 101:1581–1590 Xu L, Yang ZL, Li P, Zhou YQ (2009) Modulating effect of hesperidin on experimental murine colitis induced by dextran sulfate sodium. Phytomedicine 16:989–995